/Investor DB

412 Venture Fund — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

SovaSagesovasage.cominJun 2022

sovaSage develops technology that optimizes the CPAP mask-fitting process for sleep apnea patients.

AI & Machine LearningHealthtechMedical DevicesCentral City, US

William Kaigler(Executive Officer, Director)inDavid Mawhinney(Director)Christian Kebekus(Executive Officer, Director)Julie Kaigler(Executive Officer)

Co-investorsLife Sciences Greenhouse InvestmentsRiverfront Ventures, LLC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.